Neonatal screening for cystic fibrosis using blood trypsin with complementary meconium lactase: an advisable strategy for the population of southern Europe
- 1 March 1995
- Vol. 3 (4) , 173-179
- https://doi.org/10.1016/0925-6164(94)00021-y
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase SpecificityBiochemical Medicine and Metabolic Biology, 1993
- Newborn screening for cystic fibrosis: Its evolution and a review of the current situationScreening, 1993
- Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileusScreening, 1993
- Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: An anonymous pilot study in DenmarkScreening, 1993
- Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: Their incidence and clinical features of defined genotypesHuman Mutation, 1993
- Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.BMJ, 1991
- Growth evaluation at one year of life in infants with cystic fibrosis diagnosed by neonatal screeningPediatric Pulmonology, 1991
- Development of a Screening System for Cystic Fibrosis: Meconium or Blood Spot Trypsin Assay or Both?Acta Paediatrica, 1990
- Incidence of Cystic Fibrosis in Ethnic Italians and Greeks and in Australians of Predominantly British OriginActa Paediatrica, 1985
- Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infantsThe Journal of Pediatrics, 1983